Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer.

Autor: Gorodnova TV; N.N. Petrov Institute of Oncology., Kotiv KB; N.N. Petrov Institute of Oncology., Ivantsov AO; N.N. Petrov Institute of Oncology., Mikheyeva ON; Leningrad Regional Oncological Dispensary., Mikhailiuk GI; Leningrad Regional Oncological Dispensary., Lisyanskaya AS; City Oncological Dispensary., Mikaya NA; N.N. Petrov Institute of Oncology., Guseynov KD; N.N. Petrov Institute of Oncology., Bondarev NE; N.N. Petrov Institute of Oncology., Matveyeva NS; N.N. Petrov Institute of Oncology., Nekrasova EA; N.N. Petrov Institute of Oncology., Sidoruk AA; N.N. Petrov Institute of Oncology., Roman LD; Leningrad Regional Oncological Dispensary., Manikhas GM; City Oncological Dispensary., Belyaev AM; N.N. Petrov Institute of Oncology., Sokolenko AP, Berlev IV; N.N. Petrov Institute of Oncology., Imyanitov EN

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2018 Oct; Vol. 28 (8), pp. 1498-1506.